INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Navigating Your Holistic Approach To CCI For Biologic Drug Products
Explore regulatory framework and expectations, and see the benefit of a comprehensive approach to CCI tailored for mAbs and complex modalities such as fusion proteins or bioconjugates.
-
De-Risking A Novel Valve Component For Use With Standard Syringe Systems
A novel valve provides dual‑chamber functionality within standard syringes, keeping two liquid drugs separated until injection while reducing development risk through advanced modeling.
-
Formulation Development For Therapeutic Oligonucleotides
Discover how expert formulation and analytical support enable the development of stable, injectable oligonucleotide therapies across diverse delivery routes and molecule types.
-
Balancing Biologic Limitations And Patient Perceptions For An Enhanced Injection Experience
Discover an innovative sTW needle design reduces injection force and pain, enhancing comfort and ease for chronic patients while promoting long-term adherence through improved injection experiences.
-
Sterile Injectables: Why Innovation Matters More Than Ever1/15/2026
New technologies and regulatory changes are shaping safer, more efficient filling processes. Discover why innovation is key to protecting patients and advancing therapies.
-
MPLC System: Efficient Purification for Mid-Sized Therapeutics1/28/2026
Discover how to enhance purification for mid-sized therapeutics with advanced pressure capabilities. Learn to balance automation and regulatory compliance for more reliable, precise batches.
-
Streamline Your Path To Clinical Fill5/21/2026
Drug-independent PFS testing is a required early step — but it can be time-consuming and resource-intensive. What if you could eliminate the effort without losing the data you need?
-
A Risk-Based Decision Framework For Selecting Aseptic Barrier Technologies3/20/2026
EU GMP Annex 1 requires a risk-based approach to selecting Isolators or RABS. This framework evaluates human intervention and decontamination to ensure robust sterility assurance.
-
Fill-Finish Contract Manufacturing: Trends, Challenges, And The Future9/16/2025
See why it's important to partner with a CDMO that’s investing in advanced sterile fill-finish capabilities to meet the demands of complex biologics, gene therapies, and mRNA-based products.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
Efficient purification requires scalable chromatography and advanced automation. Explore how customizable systems and precision software optimize results for peptides, proteins, and oligonucleotides.
-
Leverage a pre-verified, integrated syringe platform. Accelerate timelines and reduce costs by eliminating drug-independent testing while streamlining regulatory submissions through one source.
-
One (1) used Vectro granulator, mdoel CF360EX, stainless steel construction, 3-5 kg capacity, xp design with controls, 220 volt, serial# CF-110, new 1982.
-
Accelerate single-cell and low-volume workflows with high precision, fast setup, and surfactant-free dispensing that delivers reproducible results and flexible performance across cell types and reagents.
-
Thermo Scientific BioProcess Containers (BPCs) and transfer assemblies are ready-to-use single-use flexible container systems for critical liquid handling applications in the biopharmaceutical and Biomanufacturing operations.
The Thermo Scientific single-use BPC product portfolio includes stocked catalog BPCs as well as custom BPCs in a variety of sizes and configurations that are manufactured at multiple facilities. This provides users with BPCs for at any step in the workflow and at any scale. Our multiple manufacturing sites help ensure an assurance of supply.